Alzheimer's Disease (AD)-like Pathology in Aged Monkeys After Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD

Overview

Journal J Neurosci

Specialty Neurology

Date 2008 Jan 4

PMID 18171917

Citations 174

Authors

Jinfang Wu

Md Riyaz Basha

Brian Brock

David P Cox

Fernando Cardozo-Pelaez

Christopher A McPherson

Jean Harry

Deborah C Rice

Bryan Maloney

Demao Chen

Debomoy K Lahiri

Nasser H Zawia

Affiliations

Soon will be listed here.

Abstract

The sporadic nature of Alzheimer's disease (AD) argues for an environmental link that may drive AD pathogenesis; however, the triggering factors and the period of their action are unknown. Recent studies in rodents have shown that exposure to lead (Pb) during brain development predetermined the expression and regulation of the amyloid precursor protein (APP) and its amyloidogenic beta-amyloid (Abeta) product in old age. Here, we report that the expression of AD-related genes [APP, BACE1 (beta-site APP cleaving enzyme 1)] as well as their transcriptional regulator (Sp1) were elevated in aged (23-year-old) monkeys exposed to Pb as infants. Furthermore, developmental exposure to Pb altered the levels, characteristics, and intracellular distribution of Abeta staining and amyloid plaques in the frontal association cortex. These latent effects were accompanied by a decrease in DNA methyltransferase activity and higher levels of oxidative damage to DNA, indicating that epigenetic imprinting in early life influenced the expression of AD-related genes and promoted DNA damage and pathogenesis. These data suggest that AD pathogenesis is influenced by early life exposures and argue for both an environmental trigger and a developmental origin of AD.

Citing Articles

Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease.

Coleman P, Delvaux E, Kordower J, Boehringer A, Huseby C Alzheimers Dement. 2025; 21(2):e14555.

PMID: 39912452 PMC: 11851168. DOI: 10.1002/alz.14555.

Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases.

Stoccoro A Biology (Basel). 2025; 14(1).

PMID: 39857328 PMC: 11761232. DOI: 10.3390/biology14010098.

Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China.

Kang Y, Feng Z, Zhang Q, Liu M, Li Y, Yang H Alzheimers Dement. 2024; 21(2):e14443.

PMID: 39713874 PMC: 11848162. DOI: 10.1002/alz.14443.

Urinary Metal Levels, Cognitive Test Performance, and Dementia in the Multi-Ethnic Study of Atherosclerosis.

Domingo-Relloso A, McGraw K, Heckbert S, Luchsinger J, Schilling K, Glabonjat R JAMA Netw Open. 2024; 7(12):e2448286.

PMID: 39621345 PMC: 11612832. DOI: 10.1001/jamanetworkopen.2024.48286.

Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases.

Stoccoro A, Coppede F Biomolecules. 2024; 14(11).

PMID: 39595543 PMC: 11591912. DOI: 10.3390/biom14111366.

References

Dalman C, Allebeck P, Cullberg J, Grunewald C, Koster M . Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch Gen Psychiatry. 1999; 56(3):234-40. DOI: 10.1001/archpsyc.56.3.234. View

Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Genda Y, Ukitsu M . Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res Mol Brain Res. 1999; 70(2):288-92. DOI: 10.1016/s0169-328x(99)00163-1. View

Osmond C, Barker D . Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect. 2000; 108 Suppl 3:545-53. PMC: 1637808. DOI: 10.1289/ehp.00108s3545. View

Morishima-Kawashima M, Oshima N, Ogata H, Yamaguchi H, Yoshimura M, Sugihara S . Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am J Pathol. 2000; 157(6):2093-9. PMC: 1885772. DOI: 10.1016/s0002-9440(10)64847-x. View

Niklowitz W, Mandybur T . Neurofibrillary changes following childhood lead encephalopathy. J Neuropathol Exp Neurol. 1975; 34(5):445-55. DOI: 10.1097/00005072-197509000-00006. View

van Erp T, Saleh P, Rosso I, Huttunen M, Lonnqvist J, Pirkola T . Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry. 2002; 159(9):1514-20. DOI: 10.1176/appi.ajp.159.9.1514. View

Cecchi C, Fiorillo C, Sorbi S, Latorraca S, Nacmias B, Bagnoli S . Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic Biol Med. 2002; 33(10):1372-9. DOI: 10.1016/s0891-5849(02)01049-3. View

Poirier L, Vlasova T . The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ Health Perspect. 2002; 110 Suppl 5:793-5. PMC: 1241247. DOI: 10.1289/ehp.02110s5793. View

Boksa P, El-Khodor B . Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci Biobehav Rev. 2003; 27(1-2):91-101. DOI: 10.1016/s0149-7634(03)00012-5. View

10.

Takiguchi M, Achanzar W, Qu W, Li G, Waalkes M . Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res. 2003; 286(2):355-65. DOI: 10.1016/s0014-4827(03)00062-4. View

11.

Christensen M, Zhou W, Qing H, Lehman A, Philipsen S, Song W . Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol Cell Biol. 2004; 24(2):865-74. PMC: 343820. DOI: 10.1128/MCB.24.2.865-874.2004. View

12.

Villa A, Santiago J, Belandia B, Pascual A . A response unit in the first exon of the beta-amyloid precursor protein gene containing thyroid hormone receptor and Sp1 binding sites mediates negative regulation by 3,5,3'-triiodothyronine. Mol Endocrinol. 2004; 18(4):863-73. DOI: 10.1210/me.2003-0260. View

13.

Rice D . Effect of lead during different developmental periods in the monkey on concurrent discrimination performance. Neurotoxicology. 1992; 13(3):583-92. View

14.

Schmitz C, Rutten B, Pielen A, Schafer S, Wirths O, Tremp G . Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol. 2004; 164(4):1495-502. PMC: 1615337. DOI: 10.1016/S0002-9440(10)63235-X. View

15.

Sambamurti K, Kinsey R, Maloney B, Ge Y, Lahiri D . Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 2004; 18(9):1034-6. DOI: 10.1096/fj.03-1378fje. View

16.

Mostafavi Abdolmaleky H, Smith C, Faraone S, Shafa R, Stone W, Glatt S . Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet. 2004; 127B(1):51-9. DOI: 10.1002/ajmg.b.20142. View

17.

Evans M, Cooke M . Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays. 2004; 26(5):533-42. DOI: 10.1002/bies.20027. View

18.

Valinluck V, Tsai H, Rogstad D, Burdzy A, Bird A, Sowers L . Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004; 32(14):4100-8. PMC: 514367. DOI: 10.1093/nar/gkh739. View

19.

Gluckman P, Hanson M . Living with the past: evolution, development, and patterns of disease. Science. 2004; 305(5691):1733-6. DOI: 10.1126/science.1095292. View

20.

Jiang Y, Sahoo T, Michaelis R, Bercovich D, Bressler J, Kashork C . A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A. 2004; 131(1):1-10. DOI: 10.1002/ajmg.a.30297. View